Cargando…
Crystal structure of [1,2,4] triazolo[4,3- b ]pyridazine derivatives as BRD4 bromodomain inhibitors and structure–activity relationship study
BRD4 contains two tandem bromodomains (BD1 and BD2) that recognize acetylated lysine for epigenetic reading, and these bromodomains are promising therapeutic targets for treating various diseases, including cancers. BRD4 is a well-studied target, and many chemical scaffolds for inhibitors have been...
Autores principales: | Kim, Jung-Hoon, Pandit, Navin, Yoo, Miyoun, Park, Tae Hyun, Choi, Ji U, Park, Chi Hoon, Jung, Kwan-Young, Lee, Byung Il |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319850/ https://www.ncbi.nlm.nih.gov/pubmed/37402749 http://dx.doi.org/10.1038/s41598-023-37527-w |
Ejemplares similares
-
Synthesis and Structure–Activity Relationships of Aristoyagonine Derivatives as Brd4 Bromodomain Inhibitors with X-ray Co-Crystal Research
por: Yoo, Minjin, et al.
Publicado: (2021) -
[1,2,4]Triazolo[4,3-a]phthalazines:
Inhibitors of Diverse Bromodomains
por: Fedorov, Oleg, et al.
Publicado: (2013) -
6-Chloro-3-(3-methylphenyl)-1,2,4-triazolo[4,3-b]pyridazine
por: Preis, Jasmin, et al.
Publicado: (2011) -
The Structural and Optical Properties of 1,2,4-Triazolo[4,3-a]pyridine-3-amine
por: Dymińska, Lucyna, et al.
Publicado: (2022) -
Synthesis, biological activity and molecular modeling study of novel 1,2,4-triazolo[4,3-b][1,2,4,5]tetrazines and 1,2,4-triazolo[4,3-b][1,2,4]triazines
por: El-Reedy, Ahmed A. M., et al.
Publicado: (2020)